OSAAI 2017 Northwest Allergy Forum
Didactic lectures allowing the speakers to provide evidence based medical recommendations, updates and expert opinion in an efficient manner.
Practicing allergists and allied health providers in the field of allergy, asthma and immunology.
Upon completion of this activity, participants should be able to:
- Improve recognition of autoinflammtory disease and the underlying pathophysiology
- Direct approbation testing and treatment for autoimflammatory disease
- Implement cost effective genetic testing for patients with atopic and immunologic disease
- Apply the appropriate treatment for nonallergic disease based on symptomatic needs of the patient
- Identify the differential diagnosis of atopic dermatitis
- Manage emerging treatments for recalcitrant atopic dermatitis
- Differentiate between asthma, COPD and asthma/COPD overlap and prescribe appropriate treatment
- Improved recognition of obstructive sleep apnea and direct appropriate referrals for testing/treatment
- Recognize the symptoms of cystic fibrosis to allow expedited testing and treatment
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma and Immunology (ACAAI) and the Oregon Society of Allergy, Asthma and Immunology (OSAAI). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma and Immunology (ACAAI) designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Attendance